Claire Bourgain
Overview
Explore the profile of Claire Bourgain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
844
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zago Baltazar R, Claerhout S, Vander Borght S, Spans L, Sciot R, Schoffski P, et al.
J Pathol Clin Res
. 2024 May;
10(3):e12376.
PMID: 38738521
The identification of gene fusions has become an integral part of soft tissue and bone tumour diagnosis. We investigated the added value of targeted RNA-based sequencing (targeted RNA-seq, Archer FusionPlex)...
2.
Dombrowski C, Bourgain C, Ma Y, Meiwald A, Pinsent A, Weynand B, et al.
Eur J Cancer Prev
. 2023 Nov;
33(3):262-270.
PMID: 37933867
Objective: To assess the costs and benefits of two algorithms for cervical cancer screening in Belgium (1) high-risk human papillomavirus (HR-HPV) primary screening and (2) HR-HPV and liquid-based cytology (LBC)...
3.
Kholova I, Negri G, Nasioutziki M, Ventura L, Capitanio A, Bongiovanni M, et al.
Cancer Cytopathol
. 2022 Jul;
130(12):939-948.
PMID: 35833701
Background: High-risk human papilloma virus (HR HPV) testing and liquid-based cytology are used for primary cervical screening. Digital cytology, based on whole-slide scanned samples, is a promising technique for teaching...
4.
Claerhout S, Lehnert S, Vander Borght S, Spans L, Dooms C, Wauters E, et al.
Lung Cancer
. 2022 Apr;
166:242-249.
PMID: 35378489
Objectives: Targeted RNA-based Next-Generation Sequencing (tRNA-seq) is increasingly being used in molecular diagnostics for gene fusion detection in non-small cell lung cancer (NSCLC). However, few data support its clinical application...
5.
Delsupehe A, Bourgain C, Bossuyt P
Gastroenterology
. 2022 Mar;
162(7):1849-1851.
PMID: 35247457
No abstract available.
6.
Haaker L, Tryssesoone L, Renders I, Verbiest A, Lerut E, Baldewijns M, et al.
Urol Oncol
. 2020 May;
38(8):686.e1-686.e9.
PMID: 32430250
Objective: Papillary renal cell carcinoma (papRCC) is a rare (10%-15%) subtype of renal cancer. Few prognostic biomarkers have been described in metastatic papRCC (m-papRCC) patients treated with vascular endothelial growth...
7.
Victoor J, Bourgain C, Vander Borght S, Vanden Bempt I, De Rop C, Floris G
Diagn Pathol
. 2020 Mar;
15(1):20.
PMID: 32127014
Background: We report an unusual case of low-grade fibromatosis-like metaplastic carcinoma (LG-FLMC) of the breast. This exceedingly rare epithelial breast malignancy has been reported only 68 times in the past...
8.
Van den Poel B, Gils S, Micalessi I, Carton S, Christiaens P, Cuyle P, et al.
Acta Clin Belg
. 2019 Oct;
76(3):177-183.
PMID: 31662122
: Empirical treatment of ri (HP) depends on the local prevalence of clarithromycin resistance but data are lacking and culturing of HP is time-consuming. We evaluated RIDA®GENE assay (r-biopharm), a...
9.
Colpaert C, Jacomen G, Van de Vijver K, Baldewijns M, Van Rompuy A, Bourgain C, et al.
Gynecol Oncol Rep
. 2019 Sep;
29:130-131.
PMID: 31517013
No abstract available.
10.
Bronswijk M, Bourgain C, Pouillon L
Gastroenterology
. 2019 Aug;
158(4):836-837.
PMID: 31404534
No abstract available.